 Endo International PLC NASDAQ: ENDP shares are trading lower by 16.86 to 0.39 after the company provided top-line results from its Phase 2 study of CCH in patients with adhesive capsulitis of the shoulder, saying the difference compared to those study participants receiving placebo. 